Sixth, Erpolat and colleagues demonstrated that CA IX, evaluated as either part of hypoxic profile molecules or as a single factor, correlated to shorter survival of high-grade glioma patients (n = 172, grade III-IV astrocytomas) [57]. This evidence concerns the gene CA9 and central nervous system cancer.